How many employees does Boehringer Ingelheim have in the US?
How many employees does Boehringer Ingelheim have in the US?
Company Description: Boehringer Ingelheim USA Corporation is located in Ridgefield, CT, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Boehringer Ingelheim USA Corporation has 3,000 total employees across all of its locations and generates $1.54 billion in sales (USD).
Who owns Boehringer Ingelheim Pharmaceuticals Inc?
Boehringer Ingelheim Auslandsbeteiligungs GmbH
Boehringer Ingelheim/Parent organizations
Is Boehringer Ingelheim a private company?
As of 2018, Boehringer Ingelheim is one of the world’s largest pharmaceutical companies, and the largest private one. Unlike most large pharmaceutical companies which are listed, the company is private and fully owned by the Boehringer, Liebrecht and von Baumbach families.
Is Boehringer Ingelheim a good company to work for?
On average, employees at Boehringer Ingelheim give their company a 4.0 rating out of 5.0 – which is 3% higher than the average rating for all companies on CareerBliss.
What drugs does Boehringer Ingelheim make?
The company develops drug therapies in the areas of cardiovascular health, oncology, respiratory, metabolic diseases, immunology and retinal health. Top-selling drugs include Spiriva, Pradaxa and Jardiance. Boehringer Ingelheim was founded in 1885 by Albert Boehringer.
Who owns buscopan?
Buscopan® | boehringer-ingelheim.ca.
Why do you want to work at Boehringer Ingelheim?
As our employees will tell you, Boehringer Ingelheim is a great place to work because we strive to create a healthy environment where meaningful work, diversity, and work-life balance are valued, resulting in more health for patients, families, communities – and employees.
Who manufactures Twynsta?
Twynsta® | boehringer-ingelheim.com.
What drug company makes Pradaxa?
Boehringer Ingelheim Pharmaceuticals, Inc. Announces Updates to Prescribing Information for Pradaxa® (dabigatran etexilate mesylate) | boehringer-ingelheim.us.
Who is the CEO of Boehringer Ingelheim animal health?
Legg and Finkler report to Jean-Michel Boers, President and CEO of Boehringer Ingelheim USA Corp. He oversees Boehringer Ingelheim’s three business units in the United States: Human Pharmaceuticals, Animal Health and Bio-Pharmaceutical Contract Manufacturing.
Who is Jean Michel Boers of Boehringer Ingelheim?
Mr. Boers came to the U.S. in 2016 as Senior Vice President of the Specialty Care Franchise, and since January 2017, has led the U.S. Human Pharma business. He earned a master’s degree in social and economic history from the University of Nijmegen (Netherlands) and an MBA from the University of Texas.
Where is the headquarters of Boehringer Ingelheim in Germany?
Operational/development sites. Boehringer Ingelheim is a globally operating company, with 146 subsidiaries around the globe. The company’s largest site and corporate headquarters is in Ingelheim am Rhein near Mainz and Frankfurt, Germany.
When did Boehringer Ingelheim merge with steag?
1998: The merging of Boehringer Ingelheim KG and Dr. Karl Thomae GmbH founds Boehringer Ingelheim Pharma KG. In 2004 the company acquired STEAG microParts GmbH. In December of the same year the company announced the acquisition of the outstanding shares of Boehringer Ingelheim Shionogi Vetmedica.
